Last reviewed · How we verify

lidocaine with propofol

Imam Abdulrahman Bin Faisal University · FDA-approved active Small molecule

lidocaine with propofol is a Local anesthetic and sedative-hypnotic combination Small molecule drug developed by Imam Abdulrahman Bin Faisal University. It is currently FDA-approved for Procedural sedation and analgesia, Local anesthesia during minor surgical procedures.

Lidocaine and propofol together provide local anesthesia and intravenous sedation by blocking sodium channels and enhancing GABAergic inhibition, respectively.

Lidocaine and propofol together provide local anesthesia and intravenous sedation by blocking sodium channels and enhancing GABAergic inhibition, respectively. Used for Procedural sedation and analgesia, Local anesthesia during minor surgical procedures.

At a glance

Generic namelidocaine with propofol
SponsorImam Abdulrahman Bin Faisal University
Drug classLocal anesthetic and sedative-hypnotic combination
TargetVoltage-gated sodium channels (lidocaine); GABA-A receptors (propofol)
ModalitySmall molecule
Therapeutic areaAnesthesia
PhaseFDA-approved

Mechanism of action

Lidocaine is a local anesthetic that blocks voltage-gated sodium channels in nerve fibers, preventing action potential propagation and pain signal transmission. Propofol is a sedative-hypnotic agent that acts as a positive allosteric modulator of GABA-A receptors, enhancing inhibitory neurotransmission in the central nervous system. The combination is used to provide both local anesthesia and systemic sedation during procedures.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about lidocaine with propofol

What is lidocaine with propofol?

lidocaine with propofol is a Local anesthetic and sedative-hypnotic combination drug developed by Imam Abdulrahman Bin Faisal University, indicated for Procedural sedation and analgesia, Local anesthesia during minor surgical procedures.

How does lidocaine with propofol work?

Lidocaine and propofol together provide local anesthesia and intravenous sedation by blocking sodium channels and enhancing GABAergic inhibition, respectively.

What is lidocaine with propofol used for?

lidocaine with propofol is indicated for Procedural sedation and analgesia, Local anesthesia during minor surgical procedures.

Who makes lidocaine with propofol?

lidocaine with propofol is developed and marketed by Imam Abdulrahman Bin Faisal University (see full Imam Abdulrahman Bin Faisal University pipeline at /company/imam-abdulrahman-bin-faisal-university).

What drug class is lidocaine with propofol in?

lidocaine with propofol belongs to the Local anesthetic and sedative-hypnotic combination class. See all Local anesthetic and sedative-hypnotic combination drugs at /class/local-anesthetic-and-sedative-hypnotic-combination.

What development phase is lidocaine with propofol in?

lidocaine with propofol is FDA-approved (marketed).

What are the side effects of lidocaine with propofol?

Common side effects of lidocaine with propofol include Hypotension, Respiratory depression, Bradycardia, Injection site pain, Dizziness.

What does lidocaine with propofol target?

lidocaine with propofol targets Voltage-gated sodium channels (lidocaine); GABA-A receptors (propofol) and is a Local anesthetic and sedative-hypnotic combination.

Related